| RS147545000 |
ZNF225
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147545395 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS147545511 |
APOBEC3B
|
Health Risk |
Conflicting classifications of pathogenicity |
APOBEC3B-related condition, APOBEC3B-related condition |
| RS1475458864 |
MMADHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Methylmalonic aciduria and homocystinuria type cblD |
| RS147546485 |
LMO7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147546808 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS147546939 |
TYR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147547509 |
SPRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147548697 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS147548960 |
OSGEP
|
Health Risk |
Conflicting classifications of pathogenicity |
OSGEP-related disorder, OSGEP-related disorder |
| RS1475492059 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS147550048 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS1475506136 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS1475508285 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS147551003 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), DGUOK-related disorder |
| RS147551342 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1475516253 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS147551647 |
YARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, lactic acidosis |
| RS147552284 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147552838 |
SLC29A3
|
Health Risk |
Conflicting classifications of pathogenicity |
H syndrome, H syndrome |
| RS147553344 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS1475539242 |
POMGNT1
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Hydrocephalus |
| RS147554026 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish type amyloidosis, Inborn genetic diseases |
| RS1475548158 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1475549372 |
IL17RC
|
Health Risk |
Conflicting classifications of pathogenicity |
Candidiasis, familial |
| RS1475552802 |
CFD
|
Health Risk |
Pathogenic |
— |
| RS1475557145 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1475559733 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS147556035 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1475566248 |
HNF1A
|
Health Risk |
Likely pathogenic |
HNF1A-related disorder, Monogenic diabetes |
| RS1475568526 |
OPA3
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 3, 3-Methylglutaconic aciduria type 3 |
| RS147556993 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS147557169 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Autoinflammatory syndrome |
| RS147557621 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1475577009 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1475578735 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS1475580175 |
MECOM
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 |
| RS147558972 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1475590979 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS147559466 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, See cases |
| RS147559626 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial amyloid nephropathy with urticaria AND deafness, Familial cold autoinflammatory syndrome 1 |
| RS147559634 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147559648 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, NTHL1-related disorder |
| RS1475598645 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS147560504 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1475605360 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
DEPDC5-related disorder, Familial focal epilepsy with variable foci |
| RS147561570 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Greig cephalopolysyndactyly syndrome |
| RS147563157 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS147563277 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS1475632900 |
BBS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1475633334 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS147563527 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS147563837 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS147564503 |
POLH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147564718 |
CFB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1475648900 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS147564959 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS147565118 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Ocular cystinosis, Nephropathic cystinosis |
| RS1475658217 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS1475661078 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Aldosterone-producing adenoma with seizures and neurological abnormalities, Aldosterone-producing adenoma with seizures and neurological abnormalities |
| RS147566416 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, Developmental malformations-deafness-dystonia syndrome |
| RS1475665992 |
F8
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Thrombophilia |
| RS1475670133 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS147567110 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS1475672414 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS147567317 |
PTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Gorlin syndrome |
| RS147567606 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS147567879 |
F9
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia, X-linked |
| RS147568171 |
PDGFRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Basal ganglia calcification |
| RS147568834 |
KRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Angiokeratoma corporis diffusum with arteriovenous fistulas, Cerebral cavernous malformation |
| RS147569168 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Congenital nephrotic syndrome |
| RS147569641 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Connective tissue disorder |
| RS1475696927 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1475702169 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS1475705727 |
EDAR
|
Health Risk |
Likely pathogenic |
Oligodontia, Ectodermal dysplasia |
| RS147571776 |
TBC1D8B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1475718221 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS1475720319 |
COASY
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 6, Neurodegeneration with brain iron accumulation 6 |
| RS147572271 |
FANCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group E, Fanconi anemia |
| RS147573850 |
ATF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS147574550 |
DNAH8
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS147574809 |
TYR
|
Health Risk |
Pathogenic |
Nonsyndromic Oculocutaneous Albinism, Nonsyndromic Oculocutaneous Albinism |
| RS1475753965 |
NDUFB10
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, Mitochondrial complex I deficiency |
| RS1475762618 |
WNT7B
|
Health Risk |
Likely pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS147576338 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Otospondylomegaepiphyseal dysplasia, autosomal recessive |
| RS147576439 |
ATP6V1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular acidosis with progressive nerve deafness, ATP6V1B1-related disorder |
| RS147576864 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, VPS13B-related disorder |
| RS1475772376 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS147577332 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS1475779672 |
MUC16
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS1475789647 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS147579680 |
DPY19L2
|
Health Risk |
Pathogenic |
Spermatogenic failure 9, Thyroid cancer |
| RS147579805 |
RFX5
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS147580001 |
DNAH8
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS147580120 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS147580372 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N |
| RS147580725 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS147580753 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS147580834 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS147580960 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |